Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.08 - $21.0 $132,970 - $34.9 Million
1,662,127 Added 20.05%
9,954,092 $602,000
Q2 2022

Aug 12, 2022

SELL
$0.16 - $0.47 $162,459 - $477,225
-1,015,373 Reduced 10.91%
8,291,965 $1.39 Million
Q1 2022

May 13, 2022

BUY
$0.42 - $0.62 $32,685 - $48,249
77,822 Added 0.84%
9,307,338 $4.38 Million
Q4 2021

Feb 14, 2022

SELL
$0.56 - $1.71 $11,732 - $35,826
-20,951 Reduced 0.23%
9,229,516 $5.26 Million
Q3 2021

Nov 12, 2021

BUY
$1.21 - $1.8 $77,875 - $115,848
64,360 Added 0.7%
9,250,467 $15.4 Million
Q2 2021

Aug 13, 2021

BUY
$1.56 - $1.98 $14.3 Million - $18.2 Million
9,186,107 New
9,186,107 $15.3 Million

Others Institutions Holding AMPE

# of Institutions
1
Shares Held
96.6K
Call Options Held
0
Put Options Held
0

About Ampio Pharmaceuticals, Inc.


  • Ticker AMPE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,287,008
  • Description
  • Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...
More about AMPE
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.